Generic Drug User Fees Will Begin With The Backlog
Executive Summary
FDA set aside fears that a separate fee for the application backlog would create administrative problems for its generic drug user fee program, instead choosing to use the queue of pending submissions to help gain more funding at launch.
You may also be interested in...
Inspection Improvements Could Help Fight Drug Shortages, Hospital Group Says
Senators also have requested a GAO study of the nature of drug shortages and FDA's ability to respond to them.
FDA Reshuffles Office Of Generic Drugs To Improve Performance
The generic drug industry can expect more streamlined reviews as a result of FDA's reorganization of the Office of Generic Drugs, according to the agency.
FDA Reshuffles Office Of Generic Drugs To Improve Performance
The generic drug industry can expect more streamlined reviews as a result of FDA's reorganization of the Office of Generic Drugs, according to the agency.